GlassScriptPhysician profile
Pradeep Nagaraju
NPI 1285615583
$4,666.78
in general payments reported to CMS, 2019-2025
34 companies · $561 in 2025
The $561 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $224 · 2021: $152 · 2022: $723 · 2023: $818 · 2024: $1,123 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,502.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $523.50 | 2022-2024 | Interstim |
| Boston Scientific Corporation | $489.84 | 2023-2025 | Upsylon, General - Female Sui, Ams 700 |
| Ferring Pharmaceuticals INC. | $430.08 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $364.58 | 2022-2025 | |
| Caldera Medical, INC | $360.55 | 2022-2023 | Desara |
| Medtronic USA, INC. | $291.50 | 2019-2020 | |
| Axonics, INC. | $258.87 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $228.39 | 2023-2025 | Gemtesa |
| Teleflex LLC | $158.49 | 2022-2023 | Urolift |
| Neotract INC. | $157.21 | 2019-2020 | |
| Astellas Pharma US INC | $133.59 | 2019-2022 | |
| Allergan, INC. | $122.67 | 2019-2022 | |
| Antares Pharma, INC. | $115.05 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $92.42 | 2019-2024 | Saffron, Speedicath |
| Laborie Medical Technologies Corp. | $89.58 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $86.65 | 2019 | |
| Merck Sharp & Dohme LLC | $86.26 | 2022-2024 | Keytruda, Welireg, Lynparza |
| Olympus America INC. | $83.83 | 2019-2025 | Itind System |
| Urovant Sciences INC | $82.58 | 2021-2022 | |
| Tolmar, INC. | $67.25 | 2024 | |
| Blue Earth Diagnostics | $61.13 | 2019-2021 | |
| Janssen Biotech, INC. | $59.12 | 2019-2024 | Akeega, Erleada |
| Pfizer INC. | $38.39 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.60 | 2019-2023 | |
| Endo USA, INC. | $36.25 | 2025 | Xiaflex |
| Urogen Pharma, INC. | $32.22 | 2021-2022 | |
| 180 Medical, INC. | $29.69 | 2022 | |
| Myriad Genetic Laboratories, INC. | $29.55 | 2023-2024 | Prolaris |
| Palette Life Sciences, INC. | $22.39 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.73 | 2019 | |
| Amgen INC. | $20.35 | 2019 | |
| Halozyme INC | $19.81 | 2023 | |
| Clarus Therapeutics INC. | $19.33 | 2021 | |
| Tempus Ai, INC | $17.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Nagaraju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.